| APC | antigen-presenting cell |
| CAR | chimeric antigen receptor |
| CTL | cytotoxic T lymphocytes |
| CTLA-4 | cytotoxic-T-lymphocyte-associated protein 4 |
| DC | dendritic cell |
| FDA | (U.S.) Food and Drug Administration |
| ICB | immune checkpoint blockade therapy |
| IFN | interferon |
| iPSC | induced pluripotent stem cell |
| MHC | major histocompatibility complex |
| MPEC | memory precursor effector cell |
| LEF | lymphocyte enhancer factor |
| MDSC | myeloid-derived suppressor cell |
| PD-1 | programmed cell death 1 |
| PD-L | programmed cell death ligand |
| SLEC | short-lived effector cell |
| T9 CAR-T | interleukin-9-secreting chimeric antigen receptor-T cell |
| TAM | tumor-associated macrophage |
| TCF1 | T cell factor 1 |
| TCM | central memory T cell |
| TCR | T cell receptor |
| TEFF | effector T cell |
| TEM | effector memory T cell |
| TEX | exhausted T cell |
| TIGIT | T cell immunoreceptor with Ig and ITIM domain |
| TIL | tumor-infiltrating lymphocyte |
| TME | tumor microenvironment |
| Treg | regulatory T cell |
| TRM | tissue-resident memory T cell |
| TSCM | stem-cell memory T cell |
| WRE | Wnt-response element |